PLAYAL®
PLAYAL® 20 mg/2mL
Formulation Concentration: 1,0 % of high molecular weight Sodium Hyaluronate (1.8 – 2.6 Mda) and 0,8% of Niacinamide
Syringe Volume: 2 mL
Administration cycle: 3 to 5 injections (under medical advice)
PLAYAL® 30 mg/2mL
Formulation Concentration: 1,5 % of high molecular weight Sodium Hyaluronate (1.8 – 2.6 Mda) and 0,8% of Niacinamide
Syringe Volume: 2 mL
Administration cycle: 3 injections (under medical advice)
PLAYAL® 36 mg/2mL
Formulation Concentration: 1,8 % of high molecular weight Sodium Hyaluronate (1.8 – 2.6 Mda) and 0,8% of Niacinamide
Syringe Volume: 2 mL
Administration cycle: 3 injections (under medical advice)
PLAYAL® 40 mg/2mL
Formulation Concentration: 2,0 % of high molecular weight Sodium Hyaluronate (1.8 – 2.6 Mda) and 0,8% of Niacinamide
Syringe Volume: 2 mL
Administration cycle: 3 injections (under medical advice)
PLAYAL® 80 mg/4 mL
Formulation Concentration: 2,0 % of high molecular weight Sodium Hyaluronate (1.8 – 2.6 Mda) and 0,5% of Niacinamide
Syringe Volume: 4 mL
Administration cycle: 1 injections (under medical advice)
CONTACTS
Innate S.r.l.
Tel. +39 01432645
info@innate.it
Viale Industria 11-13
15067 Novi ligure (AL) Italy
Via Celeste Milani, 24/26
21040 Origgio (VA) Italy
